LATS1 and neoplasm: We found that S100A16 did not affect MST1/2 expression, but decreased LATS1 protein and MOB phosphorylation, which allowed YAP to enter the nucleus triggering the downstream targets CYR61 and CTGF, which are known to stimulate the angiogenesis and tumor growth 29,30.